Skip to menu Skip to content Skip to footer

2004

Journal Article

Potential therapeutic applications of recombinant, invasive E. coli

Critchley, R, Jezzard, S, Radford, KJ, Goussard, S, Lemoine, NR, Grillot-Courvalin, C and Vassaux, G (2004). Potential therapeutic applications of recombinant, invasive E. coli. Gene Therapy, 11 (15), 1224-1233. doi: 10.1038/sj.gt.3302281

Potential therapeutic applications of recombinant, invasive E. coli

2003

Conference Publication

RNA-loading of CMRF-56 positive blood dendritic cells is a promising strategy for multiple myeloma immunotherapy.

Turtle, CJ, Radford, KJ, Allan, CP, Kato, M and Hart, DNJ (2003). RNA-loading of CMRF-56 positive blood dendritic cells is a promising strategy for multiple myeloma immunotherapy.. 45th Annual Meeting of the American-Society-of-Hematology, San Diego California, Dec 06-09, 2003. WASHINGTON: AMER SOC HEMATOLOGY.

RNA-loading of CMRF-56 positive blood dendritic cells is a promising strategy for multiple myeloma immunotherapy.

2003

Journal Article

Recombinant E. coli efficiently delivers antigen and maturation signals to human dendritic cells: Presentation of MART1 to CD8+ T cells

Radford, KJ, Jackson, AM, Wang, JH, Vassaux, G and Lemoine, NR (2003). Recombinant E. coli efficiently delivers antigen and maturation signals to human dendritic cells: Presentation of MART1 to CD8+ T cells. International Journal of Cancer, 105 (6), 811-819. doi: 10.1002/ijc.11149

Recombinant E. coli efficiently delivers antigen and maturation signals to human dendritic cells: Presentation of MART1 to CD8+ T cells

2002

Journal Article

A recombinant E. coli vaccine to promote MHC class I-dependent antigen presentation: application to cancer immunotherapy

Radford, K. J., Higgins, D. E., Pasquini, S., Cheadle, E. J., Carta, L., Jackson, A. M., Lemoine, N. R. and Vassaux, G. (2002). A recombinant E. coli vaccine to promote MHC class I-dependent antigen presentation: application to cancer immunotherapy. Gene Therapy, 9 (21), 1455-1463. doi: 10.1038/sj.gt.3301812

A recombinant E. coli vaccine to promote MHC class I-dependent antigen presentation: application to cancer immunotherapy

1997

Journal Article

Immunogenicity of CD63 in a patient with melanoma

Smith, Melanie, Bleijs, Rik, Radford, Kristen and Mersey, Peter (1997). Immunogenicity of CD63 in a patient with melanoma. Melanoma Research, 7 (SUPPL. 2)

Immunogenicity of CD63 in a patient with melanoma

1997

Journal Article

Regulation of tumor cell motility and migration by CD63 in a human melanoma cell line

Radford, KJ, Thorne, RF and Hersey, P (1997). Regulation of tumor cell motility and migration by CD63 in a human melanoma cell line. Journal of Immunology, 158 (7), 3353-3358.

Regulation of tumor cell motility and migration by CD63 in a human melanoma cell line

1996

Journal Article

CD63 associates with transmembrane 4 superfamily members, CD9 and CD81, and with β1 integrins in human melanoma

Radford, KJ, Thorne, RF and Hersey, P (1996). CD63 associates with transmembrane 4 superfamily members, CD9 and CD81, and with β1 integrins in human melanoma. Biochemical and Biophysical Research Communications, 222 (1), 13-18. doi: 10.1006/bbrc.1996.0690

CD63 associates with transmembrane 4 superfamily members, CD9 and CD81, and with β1 integrins in human melanoma

1995

Journal Article

Suppression of human melanoma cell growth and metastasis by the melanoma-associated antigen CD63 (ME491)

Radford, KJ, Mallesch, J and Hersey, P (1995). Suppression of human melanoma cell growth and metastasis by the melanoma-associated antigen CD63 (ME491). International Journal of Cancer, 62 (5), 631-635. doi: 10.1002/ijc.2910620523

Suppression of human melanoma cell growth and metastasis by the melanoma-associated antigen CD63 (ME491)